Device contract manufacturing services

We offer actuator designs that are optimised for our pMDI valves, or that can be customised to your needs. Our customisable dose counting actuators are specially designed to reliably display the remaining doses in a pMDI, and come with end-of-life indication, ensuring patients know how many doses they...

Bespak®’s pMDI valves.

 Whether you need our market-leading BK357 valve platform, or optimised valves compatible with HFA-152a and HFO-1234ze low GWP propellants, our trusted team have you covered.


We are proud to collaborate with partners across the industry to...

Resyca is a joint venture that harnesses proprietary spray nozzle technology to deliver high doses of delicate biological formulations to the lungs or nasal cavity. As the  soft mist development centre within Bespak, Resyca offers comprehensive services spanning from early-stage development through to...

This important step comes as a result of Bespak’s commitment to looking beyond low Global Warming Potential (GWP) propellants for opportunities to reduce carbon footprint in the pharma industry.

The Bespak BK357 is trusted by branded pharmaceutical companies to deliver their innovations, and by generic companies for reliable product approvals. Our range has now been expanded to ensure compatibility with suspension and solution formulations using both traditional HFA propellants, and lower Global Warming Potential (GWP) propellants HFA-152a and HFO-1234ze.

Bespak’s leadership in low GWP propellant inhaler manufacturing along with significant expansion at its Holmes Chapel site strengthens Chiesi’s global supply chain resilience 

Partnership aligns with the science-based climate commitments of both companies